Copper bis(thiosemicarbazone) complexes as hypoxia imaging agents: structure-activity relationships

被引:240
作者
Dearling, JLJ
Lewis, JS
Muller, GED
Welch, MJ
Blower, PJ [1 ]
机构
[1] Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England
[2] Washington Univ, Sch Med, Edward Mallinckrodt Inst Radiol, St Louis, MO 63110 USA
来源
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY | 2002年 / 7卷 / 03期
基金
英国医学研究理事会; 英国工程与自然科学研究理事会;
关键词
radiopharmaceutical; imaging agents; copper bis(thiosemicarbazone); hypoxia; redox potential;
D O I
10.1007/s007750100291
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Copper(II) bis(thiosemicarbazone) complexes labelled with Cu-60/62/64 are useful radiopharmaceuticals for imaging blood flow and hypoxic tissues in vivo. The aim of this study was to identify structure-activity relationships within a series of analogues with different alkyl substitution patterns in the ligand, in order to design improved hypoxia imaging agents and elucidate hypoxia selectivity mechanisms. Thirteen such complexes were synthesised and characterised spectroscopically and electrochemically. The uptake of each (labelled with Cu-64) in EMT6 tumour cells in vitro under normoxic and hypoxic conditions was studied. All complexes were taken up efficiently into cells. and some showed strong hypoxia selectivity, which was highly correlated with the Cu(II/I) redox potential. Redox potentials at the low end of the range were found to be essential for hypoxia selectivity. In turn, the redox potential was strongly correlated with alkyl substitution pattern. and the most important determinant of the redox potential was the number of alkyl groups on the diimine backbone of the ligand. Several complexes in the series warrant further evaluation as hypoxia imaging agents. The radioactivity uptake/release behaviour in the cells provides insight into possible mechanisms, and a model for hypoxia-selective intracellular trapping is discussed.
引用
收藏
页码:249 / 259
页数:11
相关论文
共 38 条
[1]  
BAERGA ID, 1992, NUCL MED BIOL, V19, P697
[2]   Copper radionuclides and radiopharmaceuticals in nuclear medicine [J].
Blower, PJ ;
Lewis, JS ;
Zweit, J .
NUCLEAR MEDICINE AND BIOLOGY, 1996, 23 (08) :957-980
[3]   Towards new transition metal-based hypoxic selective agents for therapy and imaging [J].
Blower, PJ ;
Dilworth, JR ;
Maurer, RI ;
Mullen, GD ;
Reynolds, CA ;
Zheng, YF .
JOURNAL OF INORGANIC BIOCHEMISTRY, 2001, 85 (01) :15-22
[4]  
BOOTH BA, 1967, MOL PHARMACOL, V3, P290
[5]   REACTIONS OF BIS THIOSEMICARBAZONATO COPPER(II) COMPLEXES WITH TUMOR-CELLS AND MITOCHONDRIA [J].
CHANSTIER, CH ;
MINKEL, D ;
PETERING, DH .
BIOINORGANIC CHEMISTRY, 1976, 6 (03) :203-217
[6]  
Cook GJR, 1998, J NUCL MED, V39, P99
[7]  
DEARLING J, 1990, TECHNETIUM RHENIUM O, V5, P599
[8]  
Dearling J.L.J., 1999, Journal of Labelled Compounds and Radiopharmaceuticals, V42, pS276
[9]   Redox-active metal complexes for imaging hypoxic tissues: structure-activity relationships in copper(II) bis(thiosemicarbazone) complexes [J].
Dearling, JLJ ;
Lewis, JS ;
McCarthy, DW ;
Welch, MJ ;
Blower, PJ .
CHEMICAL COMMUNICATIONS, 1998, (22) :2531-2532
[10]   Design of hypoxia-targeting radiopharmaceuticals: selective uptake of copper-64 complexes in hypoxic cells in vitro [J].
Dearling, JLJ ;
Lewis, JS ;
Mullen, GED ;
Rae, MT ;
Zweit, J ;
Blower, PJ .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1998, 25 (07) :788-792